NCT03128866View on ClinicalTrials.gov

Tranexamic Acid in Reducing Blood Loss in Patients With Pelvic Tumors Undergoing Hemipelvectomy Surgery

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

May 19, 2017

Primary Completion Date

May 31, 2026

Study Completion Date

May 31, 2026

Conditions
Pelvic Mass
Interventions
PROCEDURE

Hemipelvectomy

Undergo hemipelvectomy

DRUG

Tranexamic Acid

Given IV

Trial Locations (1)

77030

RECRUITING

M D Anderson Cancer Center, Houston

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

M.D. Anderson Cancer Center

OTHER